Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urograffin for adhesive small bowel obstruction in Ethiopia
PACTR202406577620935Not yet recruiting
- Sponsor
- Nichole Starr
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of diatrizoate meglumine in small bowel obstruction (SBO) (2 arms), sponsored by Nichole Starr. Primary endpoint: Completion of urograffin protocol. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
diatrizoate meglumine
03
Conditions
small bowel obstruction (SBO)
Beyond the preview
Go deeper on PACTR202406577620935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202406577620935.